Robert Greenberg - Second Sight President CEO, Director

EYESDelisted Stock  USD 4.14  0.20  4.61%   

CEO

Dr. Robert J. Greenberg, M.D., Ph.D., is Director of the Company since 2018.
Age 48
Tenure 6 years
Professional MarksPh.D
Phone818 833-5000
Webwww.secondsight.com
Greenberg served as the President, Chief Executive Officer and Director of Second Sight Medical Products, Inc. since its inception until August 2016. Prior to the formation of Second Sight, Dr. Greenberg worked comanaging the Alfred E. Mann Foundation and since February 2007 he was chairman of that foundation. From 1997 to 1998, he served as lead reviewer for IDEs and 510s at the Office of Device Evaluation at the US Food and Drug Administration in the Neurological Devices Division. In 1998, he received his medical degree from The Johns Hopkins School of Medicine. From 1991 to 1997, Dr. Greenberg conducted preclinical trials demonstrating the feasibility of retinal electrical stimulation in patients with retinitis pigmentosa. This work was done at the Wilmer Eye Institute at Johns Hopkins in Baltimore and led to the granting of his Ph.D. from the Johns Hopkins Department of Biomedical Engineering

Second Sight Management Efficiency

The company has return on total asset (ROA) of (10.74) % which means that it has lost $10.74 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (19.02) %, meaning that it created substantial loss on money invested by shareholders. Second Sight's management efficiency ratios could be used to measure how well Second Sight manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 199 K in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. Second Sight Medical has a current ratio of 24.75, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Second Sight until it has trouble settling it off, either with new capital or with free cash flow. So, Second Sight's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Second Sight Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Second to invest in growth at high rates of return. When we think about Second Sight's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 3 records

CEO Age

Timothy MattkeMGIC Investment Corp
48
James ScholhamerUltra Clean Holdings
58
Patrick SinksMGIC Investment Corp
61
Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. The company was founded in 1998 and is headquartered in Sylmar, California. Second Sight operates under Medical Devices classification in the United States and is traded on NAS Exchange. It employs 15 people. Second Sight Medical (EYES) is traded on NASDAQ Exchange in USA and employs 15 people.

Management Performance

Second Sight Medical Leadership Team

Elected by the shareholders, the Second Sight's board of directors comprises two types of representatives: Second Sight inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Second. The board's role is to monitor Second Sight's management team and ensure that shareholders' interests are well served. Second Sight's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Second Sight's outside directors are responsible for providing unbiased perspectives on the board's policies.
John Blake, CFO
Patrick Ryan, COO
Frank Vandeputte, Vice President General Manager
Anthony Moses, Commercial Vice President - Americas
Edward Randolph, VP of Manufacturing
Gregg Williams, Independent Director
Alfred Mann, Co-Founder, Chairman Emeritus, Member of Audit Committee, Member of Nominating and Governance Committee and Member of Compensation Committee
Jonathan McGuire, President CEO, Director
Stephen Okland, Commercial Vice President U.S. and Canada
Gregoire Cosendai, VP of European Operations
Steven Okland, Commercial Vice President U.S. and Canada
William Link, Independent Director
Thomas Miller, CFO
James Miller, Director - Manufacturing
Will McGuire, President CEO, Director
David Jacques, Vice President - Research & Development
Aaron Mendelsohn, Director
Robert Greenberg, President CEO, Director
Matthew Pfeffer, Independent Director

Second Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Second Sight a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Second Sight in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Second Sight's short interest history, or implied volatility extrapolated from Second Sight options trading.

Pair Trading with Second Sight

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Second Sight position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Second Sight will appreciate offsetting losses from the drop in the long position's value.

Moving against Second Stock

  0.77ALGN Align Technology Financial Report 24th of April 2024 PairCorr
  0.74EW Edwards Lifesciences Corp Financial Report 24th of April 2024 PairCorr
  0.71BSX Boston Scientific Corp Financial Report 24th of April 2024 PairCorr
  0.69ZBH Zimmer Biomet Holdings Financial Report 7th of May 2024 PairCorr
  0.68SYK Stryker Financial Report 6th of May 2024 PairCorr
The ability to find closely correlated positions to Second Sight could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Second Sight when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Second Sight - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Second Sight Medical to buy it.
The correlation of Second Sight is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Second Sight moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Second Sight Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Second Sight can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
Note that the Second Sight Medical information on this page should be used as a complementary analysis to other Second Sight's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Consideration for investing in Second Stock

If you are still planning to invest in Second Sight Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Second Sight's history and understand the potential risks before investing.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Transaction History
View history of all your transactions and understand their impact on performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Technical Analysis
Check basic technical indicators and analysis based on most latest market data